Infant Formula Safety Modernization Act of 2026
Referred to the House Committee on Energy and Commerce.
Summary
The bill amends the Federal Food, Drug, and Cosmetic Act to require infant formula manufacturers to regularly test both their facilities and finished products for specified harmful microbes, including clostridium botulinum. If a test is positive, the company must notify the FDA within one business day, and the agency must inform the relevant House and Senate committees the next business day. The changes are intended to strengthen oversight and protect infants from contaminated formula.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when HR 7867 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track HR 7867 freeOr ask your AI assistant about HR 7867 directly:
Add to Claude, ChatGPT or Cursor